Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New Millennium.

doi:10.1210/jc.2017-01884

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New Millennium.

The Journal of clinical endocrinology and metabolism - 1 Jan 2018

Raue Friedhelm, Dralle Henning, Machens Andreas, Bruckner Thomas, Frank-Raue Karin

Abstract excerpt

Context: Recent long-term outcomes and survival data are lacking for patients with multiple endocrine neoplasia type 2B (MEN2B). Objectives: To analyze long-term MEN2B outcomes and define prognostic factors. Design, Setting, and Participants: Retrospective comparative study of 75 patients with MEN2B from two German tertiary referral centers. Patients diagnosed and treated before and after 2000 were compared for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Carcinoma, Medullary
Share to Follow-Up Studies
Share to Multiple Endocrine Neoplasia Type 2b

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins c-ret

Share to Survival Rate

Share to Thyroid Neoplasms

Share to Thyroidectomy

Source

Open in PubMed

Identifiers

PMID: 29077903
DOI: 10.1210/jc.2017-01884

Genes

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.